Skip to main content

Table 1 Summary of baseline characteristics and demographic data

From: Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study

Age (yrs)

Height (cm)

Weight (kg)

Sex (F/M)

PEFR (L/min)

FEV1(% predicted)

Mean (SD)

Mean (SD)

Mean (SD)

N (%)

Mean (SD)

Mean % (SD)

Children with asthma (age 6–11; n = 23)

8.57 (2.00)

134.26 (18.25)

37.08 (13.64)

F 9 (39.13)

182.74 (88.01)

Not applicable

M 14 (60.87)

Adolescents with asthma (age 12–17; n = 27)

14.52 (1.55)

160.54 (7.63)

57.73 (12.17)

F 14 (51.85)

310.07 (104.36)

64.63 (15.89)

M 13 (48.15)

Adults with asthma (age 18–45; n = 50)

34.74 (7.69)

168.06 (4.92)

75.48 (10.49)

F 29 (58.00)

329.48 (101.51)

69.28 (16.63)

M 21 (42.00)

Adults with COPD (age > 50; n = 50)

66.82 (7.98)

168.74 (6.94)

78.09 (13.62)

F 28 (56.00)

216.48 (93.25)

51.88 (21.90)

M 22 (44.00)

Healthy volunteers (age 18–45; n = 50)

32.62 (7.34)

171.20 (7.86)

73.82 (14.07)

F 29 (58.00)

479.30 (127.58)

95.76 (14.31)

M 21 (42.00)